Jean‐Charles Lancelot

Author

Centre d'Etudes et de Recherche sur le Médicament de Normandie

Also Known As

J C Lancelot, J. C. LANCELOT, J. C. Lancelot, J.-C. Lancelot, J.C. Lancelot, J.‐C. LANCELOT, JEAN CHARLES LANCELOT, JEAN-CHARLES LANCELOT, JEANCHARLES LANCELOT, Jean-Charles LANCELOT

242

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Centre d'Etudes et de Recherche sur le Médicament de Normandie Université de Caen Normandie Normandie Université Centre National de la Recherche Scientifique Assiut University

About

Jean‐Charles Lancelot is an author at Centre d'Etudes et de Recherche sur le Médicament de Normandie specializing in organic chemistry, chemistry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	15	19	699
2	Medicine	15	17	466
3	Natural Sciences	15	21	415
4	Health Sciences	1	1	14
5	Social Sciences	1	1	35

Jean‐Charles Lancelot

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Synthesis of novel halopyridinylboronic acids and esters. Part 4: Halopyridin-2-yl-boronic acids and esters are stable, crystalline partners for classical Suzuki cross-coupling Alexandre Bouillon, Jean‐Charles Lancelot, Jana Sopková‐de Oliveira Santos, Tetrahedron Cross-coupling ReactionEngineeringNovel Halopyridinylboronic AcidsOrganic ChemistryClassical Suzuki Cross-coupling	2003	92
Synthesis of novel halopyridinylboronic acids and esters. Part 1: 6-Halopyridin-3-yl-boronic acids and esters Alexandre Bouillon, Jean‐Charles Lancelot, Valérie Collot, Tetrahedron EngineeringNovel Halopyridinylboronic AcidsOrganic ChemistryChemistry6-Halopyridin-3-yl-boronic Acids	2002	88
Synthesis of novel halopyridinylboronic acids and esters. Part 2: 2,4, or 5-Halopyridin-3-yl-boronic acids and esters Alexandre Bouillon, Jean‐Charles Lancelot, Valérie Collot, Tetrahedron 5-Halopyridin-3-yl-boronic AcidsEngineeringNovel Halopyridinylboronic AcidsOrganic ChemistryChemistry	2002	77
Novel Selective and Partial Agonists of 5-HT<sub>3</sub>Receptors. Part 1. Synthesis and Biological Evaluation of Piperazinopyrrolothienopyrazines Sylvain Rault, Jean‐Charles Lancelot, Hervé Prunier, Journal of Medicinal Chemistry	1996	69
Novel and Selective Partial Agonists of 5-HT<sub>3</sub> Receptors. 2. Synthesis and Biological Evaluation of Piperazinopyridopyrrolopyrazines, Piperazinopyrroloquinoxalines, and Piperazinopyridopyrroloquinoxalines Hervé Prunier, Sylvain Rault, Jean‐Charles Lancelot, Journal of Medicinal Chemistry	1997	64
Synthesis of novel halopyridinylboronic acids and esters. Part 3: 2, or 3-Halopyridin-4-yl-boronic acids and esters Alexandre Bouillon, Jean‐Charles Lancelot, Valérie Collot, Tetrahedron 3-Halopyridin-4-yl-boronic AcidsEngineeringNovel Halopyridinylboronic AcidsOrganic ChemistryChemistry	2002	64
Evaluation of Analgesic and Anti-inflammatory Activity of Novel .BETA.-Lactam Monocyclic Compounds. Carmela Saturnino, Bruno M. Fusco, Paola Saturnino, Biological and Pharmaceutical Bulletin	2000	60
An Efficient Two-Step Total Synthesis of the Quaterpyridine Nemertelline Alexandre Bouillon, Anne Sophie Voisin, Audrey Robic, The Journal of Organic Chemistry Multigram Scale SynthesisCombinatorial ChemistryQuaterpyridine NemertellineDiversity Oriented SynthesisEngineering	2003	58
Synthesis of novel pyrazolopyrrolopyrazines, potential analogs of sildenafil Marina Kopp, Jean‐Charles Lancelot, Patrick Dallemagne, Journal of Heterocyclic Chemistry Molecular PharmacologyNovel PyrazolopyrrolopyrazinesUrologyErectile DysfunctionPotential Clinical Interest	2001	56
Design, synthesis and antiproliferative activity of tripentones: A new series of antitubulin agents Vincent Lisowski, Cécile Enguehard‐Gueiffier, Jean‐Charles Lancelot, Bioorganic & Medicinal Chemistry Letters BiochemistryAntitubulin AgentsAntiproliferative ActivityMedicineNew Series	2001	47

Page 1